Spero Therapeutics, Inc.SPRONASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank33
Studio
Year-over-Year Change

Free cash flow yield

Latest
-42.12%
↓ 14% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthFair Value
Average
-36.89%
Historical baseline
PeriodValueYoY Change
2024-42.12%+1.1%
2023-42.59%-258.2%
2022-11.89%-
20210.00%+100.0%
2020-19.82%+31.2%
2019-28.81%+32.6%
2018-42.74%+66.8%
2017-128.76%-228.3%
2016-39.22%-202.7%
2015-12.95%-